# Henry Schein Inc: overview

HSIC · Nasdaq · CIK 1000228 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/hsic.md) · [Financials](/companies/hsic/financials.md) · [Filings](/companies/hsic/filings.md) · [Insiders](/companies/hsic/insiders.md)

Latest reported revenue: [$3.46bn](/filings/0001000228-26-000045.md) for Q2 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001000228-26-000045).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,174](/filings/0001000228-25-000066.md) | [3,191 d](/filings/0001000228-26-000013.md) | [3,168](/filings/0001000228-26-000024.md) | [3,240](/filings/0001000228-26-000045.md) | [3,339](/filings/0001000228-25-000066.md) | [3,437 d](/filings/0001000228-26-000013.md) | [3,368](/filings/0001000228-26-000024.md) | [3,458](/filings/0001000228-26-000045.md) |
| Gross margin | % | [31.3%](/filings/0001000228-25-000066.md) | [31.1% d](/filings/0001000228-26-000013.md) | [31.6%](/filings/0001000228-26-000024.md) | [31.4%](/filings/0001000228-26-000045.md) | [30.7%](/filings/0001000228-25-000066.md) | [30.9% d](/filings/0001000228-26-000013.md) | [31.8%](/filings/0001000228-26-000024.md) | [31.8%](/filings/0001000228-26-000045.md) |
| Operating margin | % | [4.9%](/filings/0001000228-25-000066.md) | [4.9% d](/filings/0001000228-26-000013.md) | [5.5%](/filings/0001000228-26-000024.md) | [4.7%](/filings/0001000228-26-000045.md) | [4.9%](/filings/0001000228-25-000066.md) | [4.7% d](/filings/0001000228-26-000013.md) | [5.4%](/filings/0001000228-26-000024.md) | [4.9%](/filings/0001000228-26-000045.md) |
| Net margin | % | [3.1%](/filings/0001000228-25-000066.md) | [2.9% d](/filings/0001000228-26-000013.md) | [3.5%](/filings/0001000228-26-000024.md) | [2.7%](/filings/0001000228-26-000045.md) | [3.0%](/filings/0001000228-25-000066.md) | [2.9% d](/filings/0001000228-26-000013.md) | [3.2%](/filings/0001000228-26-000024.md) | [2.7%](/filings/0001000228-26-000045.md) |
| Diluted EPS | $ per share | [0.78](/filings/0001000228-25-000066.md) | not reported | [0.88](/filings/0001000228-26-000024.md) | [0.70](/filings/0001000228-26-000045.md) | [0.84](/filings/0001000228-25-000066.md) | not reported | [0.92](/filings/0001000228-26-000024.md) | [0.82](/filings/0001000228-26-000045.md) |
| Free cash flow | $m | [117 d](/filings/0001000228-25-000066.md) | [168 d](/filings/0001000228-26-000013.md) | [6.0](/filings/0001000228-26-000024.md) | [88.0 d](/filings/0001000228-26-000045.md) | [141 d](/filings/0001000228-25-000066.md) | [338 d](/filings/0001000228-26-000013.md) | [(122)](/filings/0001000228-26-000024.md) | [212 d](/filings/0001000228-26-000045.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-25) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.4](/filings/0001000228-24-000011.md) | [12.6](/filings/0001000228-25-000014.md) | [12.3](/filings/0001000228-26-000013.md) | [12.7](/filings/0001000228-26-000013.md) | [13.2](/filings/0001000228-26-000013.md) |
| Gross margin | % | [29.6%](/filings/0001000228-24-000011.md) | [30.3%](/filings/0001000228-25-000014.md) | [31.3%](/filings/0001000228-26-000013.md) | [31.7%](/filings/0001000228-26-000013.md) | [31.1%](/filings/0001000228-26-000013.md) |
| Operating margin | % | [6.9%](/filings/0001000228-24-000011.md) | [5.9%](/filings/0001000228-25-000014.md) | [5.0%](/filings/0001000228-26-000013.md) | [4.9%](/filings/0001000228-26-000013.md) | [5.0%](/filings/0001000228-26-000013.md) |
| Net margin | % | [5.1%](/filings/0001000228-24-000011.md) | [4.3%](/filings/0001000228-25-000014.md) | [3.4%](/filings/0001000228-26-000013.md) | [3.1%](/filings/0001000228-26-000013.md) | [3.0%](/filings/0001000228-26-000013.md) |
| Diluted EPS | $ per share | [4.45](/filings/0001000228-24-000011.md) | [3.91](/filings/0001000228-25-000014.md) | [3.16](/filings/0001000228-26-000013.md) | [3.05](/filings/0001000228-26-000013.md) | [3.27](/filings/0001000228-26-000013.md) |
| Free cash flow | $bn | [0.6](/filings/0001000228-24-000011.md) | [0.5](/filings/0001000228-25-000014.md) | [0.4](/filings/0001000228-26-000013.md) | [0.7](/filings/0001000228-26-000013.md) | [0.6](/filings/0001000228-26-000013.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hsic/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Kohlberg Kravis Roberts & Co. L.P.](/funds/1399770.md) | 2026-06-30 | $1.31bn | 15,652,032 |  | Unchanged |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $630.9m | 7,553,901 |  | Added +1,831,752 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $586.7m | 7,024,663 |  | Added +1,674 |
| [Artisan Partners Limited Partnership](/funds/1466153.md) | 2026-06-30 | $540.2m | 6,467,467 |  | Reduced −105,556 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $530.1m | 6,346,669 |  | Reduced −76,498 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $366.4m | 4,342,929 |  | Reduced −219,583 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $359.6m | 4,305,276 |  | Reduced −73,705 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $345.2m | 4,133,442 |  | Reduced −61,478 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $288.7m | 3,457,175 |  | Reduced −137,184 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $283.5m | 3,394,242 |  | Added +521,238 |

## Recent filings

[All 1,672 filings](/companies/hsic/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 11:00 ET | [8-K](/filings/0001193125-26-417409.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-417409 |
| 2026-09-22 | 10:35 ET | [8-K](/filings/0001193125-26-397208.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-397208 |
| 2026-08-04 | 15:58 ET | [10-Q](/filings/0001000228-26-000045.md) | Quarterly report, period 2026-06-27 | 0001000228-26-000045 |
| 2026-08-04 | 10:13 ET | [8-K](/filings/0001000228-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000228-26-000043 |
| 2026-07-30 | 11:00 ET | [8-K](/filings/0001193125-26-324857.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324857 |
| 2026-05-22 | 12:00 ET | [8-K](/filings/0001193125-26-235496.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-235496 |
| 2026-05-05 | 17:14 ET | [10-Q](/filings/0001000228-26-000024.md) | Quarterly report, period 2026-03-28 | 0001000228-26-000024 |
| 2026-05-05 | 10:14 ET | [8-K](/filings/0001000228-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000228-26-000021 |
| 2026-04-08 | 11:00 ET | [DEF 14A](/filings/0001193125-26-146317.md) | Proxy statement, period 2026-05-21 | 0001193125-26-146317 |
| 2026-03-10 | 21:15 ET | [SCHEDULE 13D/A](/filings/0001140361-26-008844.md) | Ownership report, active investor, amended | 0001140361-26-008844 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 27, 2025](/filings/0001000228-26-000013.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c57e8e70-e944-43f8-a84f-ca91b65d5880)

## About the filer

- CIK: 1000228
- Tickers: HSIC
- Exchange: Nasdaq
- SIC code: 5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.